MTOR and colon carcinoma: Accordingly, recent work demonstrated that leptin-triggered activation of the mechanistic target of rapamycin (mTOR) in intestinal epithelial cells can drive intracellular lipid accumulation together with augmented cell cycle entry (39), revealing a mechanism that may contribute to obesity-enhanced susceptibility to colon carcinoma.